NCT03706430View on ClinicalTrials.gov

Validation of RPVi as a Parameter to Predict Fluid Responsiveness

TerminatedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

October 20, 2021

Study Completion Date

October 20, 2021

Conditions
SurgeryAnesthesia
Interventions
DEVICE

Pulse CO-Oximeter sensor

Investigational Pulse CO-Oximeter sensor will measure hemoglobin (SpHb), Pulse Rate (PR), Perfusion Index (Pi), Methemoglobin (SpMet), Pleth Variability Index (PVi), RPVi, etc.

Trial Locations (1)

90095

University of California, Los Angeles, Los Angeles

Sponsors

Lead Sponsor

Masimo Corporation
All Listed Sponsors
lead

Masimo Corporation

INDUSTRY

NCT03706430 - Validation of RPVi as a Parameter to Predict Fluid Responsiveness | Biotech Hunter | Biotech Hunter